Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Jorcyk

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Gene|November 15, 1988
A heat-shock-inducible eukaryotic expression vectorC W Schweinfest, C L Jorcyk, S Fujiwara, et al.
Oncogene|April 1, 1991
The human ETS1 gene: genomic structure, promoter characterization and alternative splicingC L Jorcyk, D K Watson, G J Mavrothalassitis, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 1, 1997
Multiple regulatory regions control the expression of Ets-1 in the developing mouse: vascular expression conferred by intron IC L Jorcyk, L J Garrett, I G Maroulakou, et al.
Cancer Gene Therapy|February 24, 2001
Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21M A Shibata, K Yoshidome, E Shibata, et al.
Molecular Carcinogenesis|November 19, 1997
Reduced p53 dosage associated with mammary tumor metastases in C3(1)/TAG transgenic miceI G Maroulakou, M A Shibata, C L Jorcyk, et al.
Oncogene|October 1, 1990
Molecular organization and differential polyadenylation sites of the human ETS2 geneD K Watson, G J Mavrothalassitis, C L Jorcyk, et al.
Toxicologic Pathology|March 21, 1998
The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancerM A Shibata, C L Jorcyk, M L Liu, et al.
Science (New York, N.Y.)|November 30, 1984
Diagnostic potential for human malignancies of bacterially produced HTLV-I envelope proteinK P Samuel, J A Lautenberger, C L Jorcyk, et al.
Pathology International|May 20, 1998
Expression of KAI1 in paraffin-embedded normal, hyperplastic and neoplastic prostate and prostate carcinoma cell linesJ M Ward, N Konishi, M Ohshima, et al.
Cancer Research|July 1, 1996
p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinomaM A Shibata, I G Maroulakou, C L Jorcyk, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Gene|November 15, 1988
A heat-shock-inducible eukaryotic expression vectorC W Schweinfest, C L Jorcyk, S Fujiwara, et al.
Oncogene|April 1, 1991
The human ETS1 gene: genomic structure, promoter characterization and alternative splicingC L Jorcyk, D K Watson, G J Mavrothalassitis, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 1, 1997
Multiple regulatory regions control the expression of Ets-1 in the developing mouse: vascular expression conferred by intron IC L Jorcyk, L J Garrett, I G Maroulakou, et al.
Cancer Gene Therapy|February 24, 2001
Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21M A Shibata, K Yoshidome, E Shibata, et al.
Molecular Carcinogenesis|November 19, 1997
Reduced p53 dosage associated with mammary tumor metastases in C3(1)/TAG transgenic miceI G Maroulakou, M A Shibata, C L Jorcyk, et al.
Oncogene|October 1, 1990
Molecular organization and differential polyadenylation sites of the human ETS2 geneD K Watson, G J Mavrothalassitis, C L Jorcyk, et al.
Toxicologic Pathology|March 21, 1998
The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancerM A Shibata, C L Jorcyk, M L Liu, et al.
Science (New York, N.Y.)|November 30, 1984
Diagnostic potential for human malignancies of bacterially produced HTLV-I envelope proteinK P Samuel, J A Lautenberger, C L Jorcyk, et al.
Pathology International|May 20, 1998
Expression of KAI1 in paraffin-embedded normal, hyperplastic and neoplastic prostate and prostate carcinoma cell linesJ M Ward, N Konishi, M Ohshima, et al.
Cancer Research|July 1, 1996
p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinomaM A Shibata, I G Maroulakou, C L Jorcyk, et al.
Pageof 2